Outcomes of HLA-Mismatched HSCT With TCRαβ/CD19 Depletion or Post-HSCT Cyclophosphamide for Inborn Errors of Immunity

Investigators performed a retrospective multicenter study via the EBMT registry on 306 children with IEI undergoing first transplant between 2010-2019 from an HLA-mismatched donor using TCRαβ or PTCY.